Xvivo Perfusion AB (XVIPF)
21.80
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Xvivo Perfusion Price : 21.80 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 21.80 | 21.80 | 21.80 | 21.80 | 0.000 |
| Oct 07, 2026 | 21.80 | 21.80 | 21.80 | 21.80 | 0.000 |
| Oct 06, 2026 | 21.80 | 21.80 | 21.80 | 21.80 | 0.000 |
| Oct 05, 2026 | 21.80 | 21.80 | 21.80 | 21.80 | 0.000 |
| Oct 02, 2026 | 21.85 | 21.85 | 21.80 | 21.80 | 1592.00 |
| Oct 01, 2026 | 22.85 | 22.85 | 22.85 | 22.85 | 0.000 |
| Sep 30, 2026 | 22.85 | 22.85 | 22.85 | 22.85 | 0.000 |
| Sep 29, 2026 | 22.85 | 22.85 | 22.85 | 22.85 | 608.00 |
| Sep 28, 2026 | 25.01 | 25.01 | 25.01 | 25.01 | 0.000 |
| Sep 25, 2026 | 25.01 | 25.01 | 25.01 | 25.01 | 0.000 |
| Sep 24, 2026 | 25.01 | 25.01 | 25.01 | 25.01 | 0.000 |
| Sep 23, 2026 | 25.01 | 25.01 | 25.01 | 25.01 | 0.000 |
| Sep 22, 2026 | 25.01 | 25.01 | 25.01 | 25.01 | 225.00 |
| Sep 21, 2026 | 25.48 | 25.48 | 25.48 | 25.48 | 0.000 |
| Sep 18, 2026 | 25.48 | 25.48 | 25.48 | 25.48 | 0.000 |
| Sep 17, 2026 | 25.67 | 25.67 | 25.48 | 25.48 | 1100.00 |
| Sep 16, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 15, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 14, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 11, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 10, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 09, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 08, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 04, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 03, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Getinge AB | 24.91 |
| Paxman AB | 3.50 |
| Enovis Corp. | 17.56 |
| Edwards Lifesciences Corp | 83.81 |
| IDEXX Laboratories, Inc. | 519.93 |
Price Related Metrics
| PE Ratio | 72.16 |
| PS Ratio | 7.179 |
| Price to Book Value | 3.021 |
| Price to Free Cash Flow | 27.33 |
| Earnings Yield | 1.39% |
| Market Cap | 686.69M |
| Operating PE Ratio | 59.01 |
| Normalized PE Ratio | 72.33 |